Progressive facial hemiatrophy and epilepsy: A common underlying dysgenetic mechanism

Neurology

Volumn 48, Issue 4, 1997, Pages 1013-1018

  Dupont, S ^a,b   Catala, M ^a   Hasboun, D ^a   Semah, F ^a,b   Baulac, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN MALFORMATION; CASE REPORT; COMPLEX PARTIAL SEIZURE; ENCEPHALOMALACIA; FEMALE; FOCAL EPILEPSY; HEMIFACIAL ATROPHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

EID: 0030983013     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4.1013     Document Type: Article

References (29)

1. Parry CH. Collections from the unpublished medical writings of the late Caleb Hillier Parry. London: Underwoods, 1825:478.
2. Romberg MH. Klinische Ergebnisse. Berlin: Forstner, 1846:75.
3. O'Leary P, Nomland R. A study of one hundred and three cases of scleroderma. Am J Med Sci 1930:180-195.
4. Tuffanelli DL, Marmelzat WL, Dorsey CS. Linear scleroderma with hemiatrophy: report of three cases associated with collagen vascular disease. Dermatologica 1966;132:51-58.
5. Archambault L, Fromm NK. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1932;7:529-584.
6. Mazzeo N, Fisher JG, Mayer MH, Mathieu GP. Progressive hemifacial atrophy (Parry-Romberg syndrome) Case report. Oral Surg 1995;79:30-35.
7. Johnson RV, Kennedy WR. Progressive facial hemiatrophy (Parry-Romberg syndrome). Controlateral extraocular muscle impairment. Am J Ophtalmol 1969;67:561-564.
8. Schwartz RA, Tedesco AS, Stern LZ, Kaminska AM, Haraldsen JM, Grekin DA. Myopathy associated with sclerodermal facial hemiatrophy. Arch Neurol 1981;38:592-594.
9. Sarnat HB. Inflammatory myopathies. Muscle pathology and histochemistry. Chicago: American Society of Clinical Pathologists Press, 1984:97-109.
10. Garcia-de-la Torre I, Castello-Sendra J, Esgleyes-Ribot T, Martinez-Bonilla G, Guerrerosantos J, Fritzler MJ. Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients. J Rheumatol 1995;22:73-77.
11. Lewkonia RM, Lowry RB. Progressive hemifacial atrophy (Parry Romberg syndrome) report with review of genetics and nosology. Am J Med Genet 1983;14:385-390.
12. Barnes L, Rodnan GP, Medsger TA, Short D. Eosinophilic fasciitis: a pathologic study of twenty cases. Am J Pathol 1979;96:493-518.
13. Faugere MC, Mussini JM, Pellissier JF, Henin D, Gray F, Brousse N. Myosites à eosinophiles et syndrome de Shulman. Sem Hôp Paris 1981;57:158-162.
14. Jablonska S. Facial hemiatrophy and its relationship to localized scleroderma. In: Jablonska S, ed. Scleroderma and pseudoscleroderma. Warsaw: Polish Medical Publishers, 1975: 537-546.
15. Wolf SD, Verity MA. Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry 1974;37: 997-1004.
16. Asher SW, Berg BO. Progressive hemifacial atrophy. Report of three cases, including one observed over 43 years, and computed tomographic findings. Arch Neurol 1982;39:44-46.
17. Fry JL, Alvarellos A, Fink CW, Blaw ME, Roach ES. Intracranial findings in progressive facial hemiatrophy. J Rheumatol 1992;19:956-958.
18. Terstegge K, Kunath B, Felber S, Speciali JG, Henkes H, Hosten N. MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. AJNR Am J Neuroradiol 1994;15:145-150.
19. Wartenberg R. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1945;54:75-96.
20. Chung MH, Sum J, Morrell MJ, Horoupian DS. Intracerebral involvement in scleroderma en Coup de Sabre: report of a case with neuropathologic findings. Ann Neurol 1995;37:679-681.
21. Pupillo G, Andermann F, Dubeau F. Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic inflammatory process. Ann Neurol 1996;39:277-278.
22. Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995;118:629-660.
23. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-153.
24. Friede RL. Dysplasia of cerebral cortex. Developmental neuropathology. 2nd ed. Springer-Verlag, 1989:330-346.
25. Kuroiwa T, Bergey GK, Rothman MI, et al. Radiologic appearance of the dysembryoplastic neuroepithelial tumor. Radiology 1995;197:233-238.
26. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws Jr ER, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Neurosurgery 1988;23:545-556.
27. Derex L, Isnard H, Revol M. Progressive facial hemiatrophy with multiple benign tumors and hamartomas. Neuropediatrics 1995;26:306-309.
28. Couly GF, Coltey PM, Le Douarin NM. The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development 1992;114:1-15.
29. Osumi-Yamashita N, Ninomiya Y, Doi H, Eto K. The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos. Dev Biol 1994;164:409-419.